Daily Iron vs Every-other-day Iron for Pediatric Patients With IDA
ConditionIron Deficiency Anemia
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age1-18
SponsorLoma Linda University
About this trial
Iron Deficiency Anemia (IDA) is a prevalent global health issue affecting a significant proportion of the population, including children. While daily oral iron supplementation is a common approach to treat IDA, concerns regarding side effects and compliance have led to exploration of alternative dosing schedules, such as every-other-day. This study aims to investigate the efficacy and safety of daily versus every other day oral iron supplementation in the management of IDA in pediatric patients.
Eligibility criteria
Qualifiers
Confirmed Iron Deficiency Anemia
Pediatric patients (1-18 years of age) without regard of gender, race, ethnicity nor language.
Able and willing to take oral iron (tablet or liquid).
Disqualifiers
Pregnant or lactating patients
Known allergies or intolerance to oral iron formulations
Concomitant chronic medical conditions affecting iron metabolism
Short gut syndrome
Trial design
Treatments tested in this trial
- iron sulfate
Treatment groups
100 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov